Carolina Clinical Research specializes in pulmonary (lung) disorders. With several trials available, we are on the front lines of developing new treatments for many pulmonary disorders, including COPD.
RPL554-CO-302: A Phase 3 Trial to Evaluate the Safety and Efficacy of Ensifentrine in Patients with COPD. Learn more here
EFC16750: Study to Assess the Efficacy, Safety, and Tolerability of SAR440340?REGN3500/Itepekimab in Chronic Obstructive Pulmonary Disease (COPD) (AERIFY-1). Learn more here